Sodium-glucose cotransporter-2 (SGLT2) inhibitors
https://www.kidney.org/atoz/content/sglt2-inhibitors
WebSGLT2 inhibitors, which are also called gliflozins, are a class of drugs that lower your blood sugar levels by preventing your kidneys from reabsorbing sugar that is created by your body and the extra sugar leaves through in your urine. Uses. Originally, SGLT2 inhibitors were developed as oral antidiabetic (blood sugar lowering) drugs.
DA: 91 PA: 18 MOZ Rank: 35